Cytochrome P450 isoforms catalyze formation of catechol estrogen quinones that react with DNA

Yan Zhang, Nilesh W. Gaikwad, Kevin Olson, Muhammad Zahid, Ercole Cavalieri, Eleanor G Rogan

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Accumulating evidence suggests that specific metabolites of estrogens, namely, catechol estrogen quinones, react with DNA to form adducts and generate apurinic sites, which can lead to the mutations that induce breast cancer. Oxidation of estradiol (E2) produces 2 catechol estrogens, 4-hydroxyestradiol (4-OHE2) and 2-OHE2 among the major metabolites. These, in turn, are oxidized to the quinones, E2-3,4-quinone (E2-3,4-Q) and E2-2,3-Q, which can react with DNA. Oxidation of E2 to 2-OHE2 is mainly catalyzed by cytochrome P450 (CYP) 1A1, and CYP3A4, whereas oxidation of E2 to 4-OHE2 in extrahepatic tissues is mainly catalyzed by CYP1B1 as well as some CYP3As. The potential involvement of CYP isoforms in the further oxidation of catechols to semiquinones and quinones has, however, not been investigated in detail. In this project, to identify the potential function of various CYPs in oxidizing catechol estrogens to quinones, we used different recombinant human CYP isoforms, namely, CYP1A1, CYP1B1, and CYP3A4, with the scope of oxidizing the catechol estrogens 2-OHE2 and 4-OHE2 to their respective estrogen quinones, which then reacted with DNA. The depurinating adducts 2-OHE2-6-N3Ade, 4-OHE2-1-N3Ade, and 4-OHE2-1-N7Gua were observed in the respective reaction systems by ultraperformance liquid chromatography/tandem mass spectrometry. Furthermore, more than 100-fold higher levels of estrogen-glutathione (GSH) conjugates were detected in the reactions. Glutathione conjugates were observed, in much smaller amounts, when control microsomes were used. Depurinating adducts, as well as GSH conjugates, were obtained when E2-3,4-Q was incubated with CYP1B1 or control microsomes in a 30-minute reaction, further demonstrating that GSH is present in these recombinant enzyme preparations. These experiments demonstrated that CYP1A1, CYP1B1, and CYP3A4 are able to oxidize catechol estrogens to their respective quinones, which can further react with GSH, protein, and DNA, the last resulting in depurinating adducts that can lead to mutagenesis.

Original languageEnglish (US)
Pages (from-to)887-894
Number of pages8
JournalMetabolism: Clinical and Experimental
Volume56
Issue number7
DOIs
StatePublished - Jul 1 2007

Fingerprint

Catechol Estrogens
Quinones
Cytochrome P-450 Enzyme System
Cytochrome P-450 CYP3A
Protein Isoforms
DNA
Estrogens
Cytochrome P-450 CYP1A1
Microsomes
Glutathione
Catechols
Tandem Mass Spectrometry
Mutagenesis
Liquid Chromatography
Estradiol
Breast Neoplasms
Mutation
Enzymes

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Cytochrome P450 isoforms catalyze formation of catechol estrogen quinones that react with DNA. / Zhang, Yan; Gaikwad, Nilesh W.; Olson, Kevin; Zahid, Muhammad; Cavalieri, Ercole; Rogan, Eleanor G.

In: Metabolism: Clinical and Experimental, Vol. 56, No. 7, 01.07.2007, p. 887-894.

Research output: Contribution to journalArticle

@article{c5d900d5a8174c16901d81d0c766b61d,
title = "Cytochrome P450 isoforms catalyze formation of catechol estrogen quinones that react with DNA",
abstract = "Accumulating evidence suggests that specific metabolites of estrogens, namely, catechol estrogen quinones, react with DNA to form adducts and generate apurinic sites, which can lead to the mutations that induce breast cancer. Oxidation of estradiol (E2) produces 2 catechol estrogens, 4-hydroxyestradiol (4-OHE2) and 2-OHE2 among the major metabolites. These, in turn, are oxidized to the quinones, E2-3,4-quinone (E2-3,4-Q) and E2-2,3-Q, which can react with DNA. Oxidation of E2 to 2-OHE2 is mainly catalyzed by cytochrome P450 (CYP) 1A1, and CYP3A4, whereas oxidation of E2 to 4-OHE2 in extrahepatic tissues is mainly catalyzed by CYP1B1 as well as some CYP3As. The potential involvement of CYP isoforms in the further oxidation of catechols to semiquinones and quinones has, however, not been investigated in detail. In this project, to identify the potential function of various CYPs in oxidizing catechol estrogens to quinones, we used different recombinant human CYP isoforms, namely, CYP1A1, CYP1B1, and CYP3A4, with the scope of oxidizing the catechol estrogens 2-OHE2 and 4-OHE2 to their respective estrogen quinones, which then reacted with DNA. The depurinating adducts 2-OHE2-6-N3Ade, 4-OHE2-1-N3Ade, and 4-OHE2-1-N7Gua were observed in the respective reaction systems by ultraperformance liquid chromatography/tandem mass spectrometry. Furthermore, more than 100-fold higher levels of estrogen-glutathione (GSH) conjugates were detected in the reactions. Glutathione conjugates were observed, in much smaller amounts, when control microsomes were used. Depurinating adducts, as well as GSH conjugates, were obtained when E2-3,4-Q was incubated with CYP1B1 or control microsomes in a 30-minute reaction, further demonstrating that GSH is present in these recombinant enzyme preparations. These experiments demonstrated that CYP1A1, CYP1B1, and CYP3A4 are able to oxidize catechol estrogens to their respective quinones, which can further react with GSH, protein, and DNA, the last resulting in depurinating adducts that can lead to mutagenesis.",
author = "Yan Zhang and Gaikwad, {Nilesh W.} and Kevin Olson and Muhammad Zahid and Ercole Cavalieri and Rogan, {Eleanor G}",
year = "2007",
month = "7",
day = "1",
doi = "10.1016/j.metabol.2007.03.001",
language = "English (US)",
volume = "56",
pages = "887--894",
journal = "Metabolism: Clinical and Experimental",
issn = "0026-0495",
publisher = "W.B. Saunders Ltd",
number = "7",

}

TY - JOUR

T1 - Cytochrome P450 isoforms catalyze formation of catechol estrogen quinones that react with DNA

AU - Zhang, Yan

AU - Gaikwad, Nilesh W.

AU - Olson, Kevin

AU - Zahid, Muhammad

AU - Cavalieri, Ercole

AU - Rogan, Eleanor G

PY - 2007/7/1

Y1 - 2007/7/1

N2 - Accumulating evidence suggests that specific metabolites of estrogens, namely, catechol estrogen quinones, react with DNA to form adducts and generate apurinic sites, which can lead to the mutations that induce breast cancer. Oxidation of estradiol (E2) produces 2 catechol estrogens, 4-hydroxyestradiol (4-OHE2) and 2-OHE2 among the major metabolites. These, in turn, are oxidized to the quinones, E2-3,4-quinone (E2-3,4-Q) and E2-2,3-Q, which can react with DNA. Oxidation of E2 to 2-OHE2 is mainly catalyzed by cytochrome P450 (CYP) 1A1, and CYP3A4, whereas oxidation of E2 to 4-OHE2 in extrahepatic tissues is mainly catalyzed by CYP1B1 as well as some CYP3As. The potential involvement of CYP isoforms in the further oxidation of catechols to semiquinones and quinones has, however, not been investigated in detail. In this project, to identify the potential function of various CYPs in oxidizing catechol estrogens to quinones, we used different recombinant human CYP isoforms, namely, CYP1A1, CYP1B1, and CYP3A4, with the scope of oxidizing the catechol estrogens 2-OHE2 and 4-OHE2 to their respective estrogen quinones, which then reacted with DNA. The depurinating adducts 2-OHE2-6-N3Ade, 4-OHE2-1-N3Ade, and 4-OHE2-1-N7Gua were observed in the respective reaction systems by ultraperformance liquid chromatography/tandem mass spectrometry. Furthermore, more than 100-fold higher levels of estrogen-glutathione (GSH) conjugates were detected in the reactions. Glutathione conjugates were observed, in much smaller amounts, when control microsomes were used. Depurinating adducts, as well as GSH conjugates, were obtained when E2-3,4-Q was incubated with CYP1B1 or control microsomes in a 30-minute reaction, further demonstrating that GSH is present in these recombinant enzyme preparations. These experiments demonstrated that CYP1A1, CYP1B1, and CYP3A4 are able to oxidize catechol estrogens to their respective quinones, which can further react with GSH, protein, and DNA, the last resulting in depurinating adducts that can lead to mutagenesis.

AB - Accumulating evidence suggests that specific metabolites of estrogens, namely, catechol estrogen quinones, react with DNA to form adducts and generate apurinic sites, which can lead to the mutations that induce breast cancer. Oxidation of estradiol (E2) produces 2 catechol estrogens, 4-hydroxyestradiol (4-OHE2) and 2-OHE2 among the major metabolites. These, in turn, are oxidized to the quinones, E2-3,4-quinone (E2-3,4-Q) and E2-2,3-Q, which can react with DNA. Oxidation of E2 to 2-OHE2 is mainly catalyzed by cytochrome P450 (CYP) 1A1, and CYP3A4, whereas oxidation of E2 to 4-OHE2 in extrahepatic tissues is mainly catalyzed by CYP1B1 as well as some CYP3As. The potential involvement of CYP isoforms in the further oxidation of catechols to semiquinones and quinones has, however, not been investigated in detail. In this project, to identify the potential function of various CYPs in oxidizing catechol estrogens to quinones, we used different recombinant human CYP isoforms, namely, CYP1A1, CYP1B1, and CYP3A4, with the scope of oxidizing the catechol estrogens 2-OHE2 and 4-OHE2 to their respective estrogen quinones, which then reacted with DNA. The depurinating adducts 2-OHE2-6-N3Ade, 4-OHE2-1-N3Ade, and 4-OHE2-1-N7Gua were observed in the respective reaction systems by ultraperformance liquid chromatography/tandem mass spectrometry. Furthermore, more than 100-fold higher levels of estrogen-glutathione (GSH) conjugates were detected in the reactions. Glutathione conjugates were observed, in much smaller amounts, when control microsomes were used. Depurinating adducts, as well as GSH conjugates, were obtained when E2-3,4-Q was incubated with CYP1B1 or control microsomes in a 30-minute reaction, further demonstrating that GSH is present in these recombinant enzyme preparations. These experiments demonstrated that CYP1A1, CYP1B1, and CYP3A4 are able to oxidize catechol estrogens to their respective quinones, which can further react with GSH, protein, and DNA, the last resulting in depurinating adducts that can lead to mutagenesis.

UR - http://www.scopus.com/inward/record.url?scp=34250011712&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34250011712&partnerID=8YFLogxK

U2 - 10.1016/j.metabol.2007.03.001

DO - 10.1016/j.metabol.2007.03.001

M3 - Article

C2 - 17570247

AN - SCOPUS:34250011712

VL - 56

SP - 887

EP - 894

JO - Metabolism: Clinical and Experimental

JF - Metabolism: Clinical and Experimental

SN - 0026-0495

IS - 7

ER -